ARTICLE | Company News
Norak, Purdue Pharma deal
October 18, 2004 7:00 AM UTC
Norak will develop cell lines that express a G protein-coupled receptor (GPCR) orphan target supplied by Purdue. Norak will use its Transfluor GPCR-based technology to develop the cell lines, which it...